Ceramedix Awarded Phase 2B NIH SBIR Grant to Evaluate the Non-Clinical Pharmacology of Its Lead Candidate to Support IND Submission ...Middle East

Approximate $3 Million Grant Will Fund Additional Research for Mitigating Illness Due to Radiation Exposure NEW YORK, Aug. 24, 2023 /PRNewswire/ -- Ceramedix Holding, LLC (Ceramedix), a privately-held biotherapeutics company developing a new class of antibody-based drugs designed with the...

Hence then, the article about ceramedix awarded phase 2b nih sbir grant to evaluate the non clinical pharmacology of its lead candidate to support ind submission was published today ( Thursday 24/08/2023 - 03:21 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Ceramedix Awarded Phase 2B NIH SBIR Grant to Evaluate the Non-Clinical Pharmacology of Its Lead Candidate to Support IND Submission )

Also on site :

• HBO Max Moves Up Forthcoming Episodes Of ‘Industry,’ ‘A Knight Of The Seven Kingdoms’ Ahead Of Super Bowl
• Why Did Taylor Swift Skip the 2026 Grammy Awards? Fans Are Disappointed
• Donald Trump Slams Grammys as ‘Unwatchable’ and Calls Trevor Noah a ‘Total Loser’ Over Trump-Epstein Island Joke: ‘It Looks Like I’ll Be Sending My Lawyers to Sue This Pathetic Dope’